Autoimmune disease therapies see boom driven by scientific breakthroughs and investment

forbes.com

Autoimmune disease therapies are experiencing a boom, with projected revenues for drugs like AbbVie's Skyrizi expected to rival top metabolic treatments. This surge is driven by scientific breakthroughs and significant venture capital investment, with immune system modulating drugs predicted to grow at over 9% annually. The field is seeing major acquisitions and the development of new treatments for complex conditions, though some experts anticipate a shift towards more niche therapies.


With a significance score of 5.1, this news ranks in the top 1% of today's 30424 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Autoimmune disease therapies see boom driven by scientific breakthroughs and investment | News Minimalist